Anti-diabetic drugs prescription pattern by postgraduate students among type 2 diabetes patients attending a tertiary care hospital

Authors

  • Lohit K. Department of Pharmacology, Sri Siddhartha Institute of Medical Sciences and Research Center, Bangalore Rural, Karnataka
  • Lakshmish Devang Halepalya Somashekar Department of Pharmacology, Sri Siddhartha Medical College, Tumkur, Karnataka
  • Naveen Kumar Department of Pharmacology, Sri Siddhartha Medical College, Tumkur, Karnataka
  • Vidya K. R. Department of Community Medicine, Sri Siddhartha Institute of Medical Sciences and Research Center, Bangalore Rural, Karnataka

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20194783

Keywords:

Anti-diabetic drugs, Diabetes, Prescription pattern, Postgraduate students

Abstract

Background: The pattern of prescribing anti-diabetic drugs varies among different medical professionals due to the availability of numerous anti-diabetic drugs and demographic and have increasingly favoured for tighter control of glycemic index. Even with the available multiple therapies many patients are not in control. The reasons may be multi factorial and the one important factor is the drugs prescribed.

Methods: This cross-sectional study involving 140 type 2 adult diabetes patients was done to assess the pattern of anti-diabetic drugs prescribed by the postgraduate students in a tertiary health care center using a specially designed questionnaire.

Results: Oral medications were predominantly prescribed. Metformin and Glimepiride combination was prescribed in majority. Among insulin, combination of short and intermediate acting insulin was prescribed more and the number of insulin prescription increased with the duration of diabetes. Interestingly no newer classes of drugs are prescribed.

Conclusions: There is a rational prescription pattern of antidiabetic drugs but newer antidiabetic drugs are not prescribed and life style changes are not discussed with the patients. There is a need to include life style changes as a part of prescription to all the patients.

 

Author Biographies

Lohit K., Department of Pharmacology, Sri Siddhartha Institute of Medical Sciences and Research Center, Bangalore Rural, Karnataka

Associate Professor, Department of Pharmacology

Lakshmish Devang Halepalya Somashekar, Department of Pharmacology, Sri Siddhartha Medical College, Tumkur, Karnataka

Department of Pharmacology

Naveen Kumar, Department of Pharmacology, Sri Siddhartha Medical College, Tumkur, Karnataka

Department of Pharmacology

Vidya K. R., Department of Community Medicine, Sri Siddhartha Institute of Medical Sciences and Research Center, Bangalore Rural, Karnataka

Department of Community Medicine

References

Joshi SR, Parikh RM. India diabetes capital of the world: now heading towards hypertension. J Assoc Physicians India. 2007;55:323-4.

Kumar A, Goel MK, Jain RB, Khanna P, Chaudhary V. India towards diabetes control: Key issues. Australas Med J. 2013;6(10):524-31.

Kaveeshwar SA, Cornwall J. The current state of diabetes mellitus in India. Aust Med J. 2014;7(1):45-8.

Fowler MJ. Microvascular and Macrovascular Complications of Diabetes. Clin Diabetes. 2008;26(2):77-82.

Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ. 2000;321:405.

Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and Trends in Obesity Among US Adults, 1999-2000. JAMA. 2002;288(14):1723-7.

Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001. JAMA. 2003;289(1):76-9.

Qaseem A, Vijan S, Snow V, Cross JT, Weiss KB, Owens DK. Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin A1c targets. A guidance statement from the American College of Physicians. Ann Intern Med 2007;147(6):417-22.

American Diabetes Association. Diabetes Care 2008;31(Supplement 1):S12-S54.

Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, et al. Guidelines on diabetes, prediabetes, and cardiovascular diseases:executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007;28(1):88-136.

Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Canadian J Diabetes. 2003;(S2):27.

Lawrenson R. Standards of medical care in diabetes: Diabetes Care. 2005;28(Suppl 1):S4-S36.

Ashutosh K, Ipseeta RM, Sandeep R. Assessment of Prescription Pattern of Antidiabetic Drugs in the Outpatient Department of a Tertiary Care Hospital. Int J Clin Endocrinol Metab. 2017;3(1):1-7.

Ginter E, Simko V. Type 2 diabetes mellitus, pandemic in 21st century. Adv Exp Med Biol. 2012;771:42-50.

Mandal S, Maiti T, Das AK, Das A, Mandal A, Sarkar BS, et al. Drug utilization study in patients with type 2 diabetes mellitus diabetes clinic of a tertiary care hospital in rural Bengal. Int J Basic Clin Pharmacol. 2016;5:1647-54.

Chu WM, Ho HE, Huang KH, Tsan YT, Liou YS, Wang YH, et al. The prescribing trend of oral antidiabetic agents for type 2 diabetes in Taiwan:An 8-year population-based study. Medicine. 2017;96(43):e8257.

Uma DP, Alex SM, Sreelekshmi BS, Smitha S, Jiji KN, Menon AS. Drug Utilization Pattern Of Antidiabetic Drugs Among Diabetic Outpatients In A Tertiary Care Hospital. Asian J Pharm Clin Res. 2015;8(2):144-6.

Downloads

Published

2019-10-22

How to Cite

K., L., Somashekar, L. D. H., Kumar, N., & K. R., V. (2019). Anti-diabetic drugs prescription pattern by postgraduate students among type 2 diabetes patients attending a tertiary care hospital. International Journal of Basic & Clinical Pharmacology, 8(11), 2454–2458. https://doi.org/10.18203/2319-2003.ijbcp20194783

Issue

Section

Original Research Articles